Tradestie Institutional Equity Comparison Engine

SKIN vs NWL โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

NWL Overall Edge

NWL Captures Institutional Edge (2โ€“2 Pillars ยท 9โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Newell Brands Inc. (NWL) driven by superior Valuation, Growth & Margin while SKIN counters with relative strength in Momentum & Technical, Options & Structure. Fundamentally, SKIN trades at 106.4x Forward P/E with 2.4% operating margin (-2.1% YoY revenue) versus NWL at 8.4x Forward P/E and 7.8% operating margin (+3.7% YoY). In options structure, SKIN sits in UNCLASSIFIED (100th %ile IV; Dealer Gamma Walls on Pro) against NWL sits in CONSOLIDATION (48th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner NWL
SKIN 106.4x vs NWL 8.4x Fwd P/E
Growth & Margin Winner NWL
Op Margin 2.4% vs 7.8% ยท YoY -2.1% vs +3.7%
Momentum & Technical Winner SKIN
1Y +1057.7% vs +73.1% ยท 52W Pos 83% vs 67%
Options & Structure Winner SKIN
UNCLASSIFIED (100th %ile IV) vs CONSOLIDATION (48th %ile IV)
SKIN NASDAQ
The Beauty Health Company Class A Common Stock
Surgical & Medical Instruments & Apparatus
$15.05
-7.73% 1D
Market Cap $106.3M
1M Return +42.52%
1Y Return +1057.69%
Forward P/E 106.4x
Unified AI Score
34.1 / 100 SELL
Tech 50.0 Fund 34.0 Flow 67.0 Mom 46.0
NWL NASDAQ
Newell Brands Inc.
Plastics Products, Nec
$5.85
+1.21% 1D
Market Cap $2.5B
1M Return +3.54%
1Y Return +73.08%
Forward P/E 8.4x
Unified AI Score
48.5 / 100 HOLD
Tech 40.0 Fund 49.0 Flow 57.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: SKIN +1057.69% NWL +73.08% Spread: +984.61 pp (SKIN Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period SKIN Revenue NWL Revenue SKIN Op. Margin NWL Op. Margin Margin Edge
FY2018 N/A $10.2B N/A -74.4% NWL
FY2019 $170M $9.71B 8.1% -5.0% SKIN
FY2020 $120M $9.38B -14.4% -6.7% NWL
FY2021 $260M $10.6B -15.4% 9.6% NWL
FY2022 $370M $9.46B -7.1% 3.3% NWL
FY2023 $400M $8.13B -32.9% -1.0% NWL
FY2024 $330M $7.58B -20.3% 0.9% NWL
FY2025 $300M $7.20B -6.9% 0.5% NWL

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: SKIN (1) vs NWL (9)
Institutional Metric SKIN NWL Criterion Row Winner
Market Capitalization Scale $106.3M $2.5B Larger Scale NWL
Trailing P/E Ratio Valuation 106.4x 7.9x Lower Multiple NWL
Forward P/E Ratio Valuation 106.4x 8.4x Lower Multiple NWL
Revenue Growth (YoY) Growth -2.1% +3.7% Higher Growth NWL
Operating Margin (TTM) Profitability 2.4% 7.8% Higher Margin NWL
Net Profit Margin Profitability -6.3% -4.4% Higher Margin NWL
Return on Equity (ROE) Capital Efficiency -30.1% -12.8% Higher ROE NWL
52-Week Range Position Momentum 83% ($0โ€“$18) 67% ($3โ€“$7) Stronger Trend SKIN
Beta / 30D Volatility Risk Regime -14.22ฮฒ ยท 192% Vol 1.28ฮฒ ยท 76% Vol Lower Realized Risk NWL
Unified Institutional Score Composite Signal 34.1 / 100 (SELL) 48.5 / 100 (HOLD) Higher Composite NWL

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full SKIN vs NWL Buy Guide
SKIN UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 100th %ile
IV Regime Extreme (>80th %ile)
Live SKIN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
NWL CONSOLIDATION
74d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 48th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live NWL Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither SKIN nor NWL registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.